YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

FDA panel: Most common oral decongestant in the US does not work

Posted online

A U.S. Food and Drug Administration medical advisory panel ruled that phenylephrine, the most common oral decongestant in the United States, does not work as designed.

The panel found that over-the-counter cold medications that use phenylephrine as a key ingredient "failed to provide any benefit over [a] placebo."

In 2022, an estimated 242 million packages of OTC cough and allergy oral products containing PE sold in retail stores, generating some $1.8 billion in sales.

Read more from Engadget.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences